Devonian Health Group Inc.
GSD.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 590.24% | 646.91% | 407.66% | 120.00% | 34.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 590.24% | 646.91% | 407.66% | 120.00% | 34.22% |
| Cost of Revenue | 673.34% | 700.83% | 454.54% | 119.54% | 18.58% |
| Gross Profit | 462.13% | 559.09% | 327.10% | 120.71% | 68.43% |
| SG&A Expenses | 68.95% | 43.30% | 36.09% | 59.16% | 15.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.86% | 3.70% | 3.48% | 1.96% | 0.34% |
| Total Operating Expenses | 220.98% | 176.05% | 105.47% | 62.58% | 19.83% |
| Operating Income | 85.69% | 79.98% | 31.94% | -22.52% | -10.04% |
| Income Before Tax | 78.83% | 73.32% | 30.57% | -11.82% | -3.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 78.83% | 73.32% | 30.57% | -11.82% | -3.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.83% | 73.32% | 30.57% | -11.82% | -3.92% |
| EBIT | 85.69% | 79.98% | 31.94% | -22.52% | -10.04% |
| EBITDA | 101.73% | 93.95% | 35.18% | -33.61% | -24.62% |
| EPS Basic | 79.73% | 75.29% | 37.74% | -0.90% | 9.39% |
| Normalized Basic EPS | 79.86% | 74.84% | 37.89% | -0.72% | 9.15% |
| EPS Diluted | 75.63% | 71.48% | 40.82% | 8.11% | 10.86% |
| Normalized Diluted EPS | 79.86% | 74.84% | 37.89% | -0.72% | 9.15% |
| Average Basic Shares Outstanding | 5.79% | 8.25% | 11.41% | 12.09% | 14.87% |
| Average Diluted Shares Outstanding | 5.79% | 8.25% | 11.41% | 12.09% | 14.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
